Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives
Davide Fiore Bavaro(Humanitas University), Annalisa Saracino(University of Bari Aldo Moro), Alessandra Belati(Humanitas University), Adriana Mosca(University of Bari Aldo Moro), Luigi Ronga(University of Bari Aldo Moro), Lucia Diella(Humanitas University), Stefania Stolfa(University of Bari Aldo Moro), Luca Scalone(University of Bari Aldo Moro), Monica Stufano(University of Bari Aldo Moro), Maria Dell’Aera(Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari), Salvatore Grasso(University of Bari Aldo Moro), Leonarda Maurmo(University of Bari Aldo Moro), Federica Romanelli(University of Bari Aldo Moro), Lidia Dalfino(Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari)
Cited by 95
Related Papers
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)
|Infection|2013|184
Lung morphology predicts response to recruitment maneuver in patients with acute respiratory distress syndrome
|Critical Care Medicine|2010|175
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)
|Clinical Infectious Diseases|2023|156
Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients
|Internal and Emergency Medicine|2022|113